Drugs / GSK Bio MenACWY-TT
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00126984 | Jul 2005 → Feb 2008 | meningococcal infection | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GSK Bio MenACWY-TT | “GSK Bio MenACWY-TT Conjugate Vaccine” NCT00126984 ↗ |
| Modality | Vaccine | “Conjugated meningococcal ACWY-TT (vaccine)” NCT00126984 ↗ |
| Route | Intramuscular | “One intramuscular dose during the primary vaccination” NCT00126984 ↗ |